Dendritic cell Flt3 - regulation, roles and repercussions for immunotherapy.

Dendritic cells (DCs) are essential for initiating immune responses. Depending on the environment, the type of DC and the way in which it interacts with T cells; these immune responses can be beneficial or detrimental. DCs can be exploited as cellular vectors for vaccines against infection and cancer. The development and maintenance of DCs is dependent on the FMS-like tyrosine kinase 3 (Flt3)/Flt3 ligand (Flt3L) signaling cascade. Flt3 is also one of the most commonly mutated genes in leukemia and as such represents an attractive drug target. In this review, Flt3 is discussed with a particular focus on DCs. We detail the lifecycle of Flt3, from transcription to degradation, and interrogate recent studies as to how this pathway can be manipulated for immunotherapy, vaccination and treatment of autoimmune disease. This article is protected by copyright. All rights reserved.